New FDA rules for TV drug ads: Simpler language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
Robert Kennedy Jr. Poised To Lead Health And Human Services: Why FDA, NIH Officials Are Nervous
Federal employees are concerned over President-elect Donald Trump’s pick, Robert F. Kennedy Jr., to lead the Department of ...
CCHR Int2d
CCHR Urges FDA Overhaul to End Psychiatric Drug and Device Harms
The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.
Robert F. Kennedy Jr.’s Views Now Matter for the Nation. Here’s How He Could Influence Food and Drug Policy
Robert F. Kennedy Jr is known as a persistent critic of vaccine safety and is a longtime antagonist of the Food and Drug ...
What Robert F. Kennedy Jr. has said about vaccines, fluoride and food dye as Trump nominates him to head the Department of Health and Human Services
President-elect Donald Trump has named Robert F. Kennedy Jr. as his choice for the next secretary of the Department of Health ...
Reuters1mon
US FDA expands use of Avadel's sleep disorder drug to ages 7 and up
Oct 17 - The U.S. Food and Drug Administration has approved Avadel ... approved for the same condition as Lumryz, Xywav has the FDA's expanded nod to treat idiopathic hypersomnia, a rare ...
FDA Grants Orphan Drug Designation to Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy
Research that was carried out by Baylor College of Medicine and Texas Children’s Hospital doctors have led to the U.S. Food ...
Business Wire1mon
Papillon Therapeutics Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich's Ataxia
today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to Papillon’s PPL-001, an experimental treatment for Friedreich's ataxia.
Acsh.org3d
The Media and I: Hurricane Helene and Drug Shortages
Mark Hahn and I discuss the critical vulnerabilities in the U.S. drug supply from Hurricanes Helene and Milton.